Category: Biotech, Food, Drug

2022: Who Were You in 2022? Here’s a recap of the Hot Issues for 2022.

FDA Issues the 2022 Edition of its Food Code

The Future of Doctor-Patient Relationships & Medical Marijuana

H.R. 2617) – Cosmetics Summary

FTC Revises the Long-standing “Dietary Supplement Guide” in order to cover all health products

FDA Issues Final Guidance Regarding GRAS Panel Best Practices

Extended Comment Period for “Healthy Regulations”; However, Consumer Class Actions Targeting “Health Halos”, May Continue

OSTP publishes RFIs for Coordinated Framework for Regulation of Biotechnology and National Biotechnology and Biomanufacturing Initiative

Office of Science and Technology Policy requests public input on Biotechnology Regulation

340B Hospital Reimbursement – Update – Underpayments & the Need to Act Now

Psychedelic Drugs – Easing the Regulatory Hurdles for Development

FDA Published Food Safety Culture Literature Review